CXCR4 and prostate cancer: CXCR4 is another adhesion molecule that has been implicated in the acquisition of invasive [38] and metastatic phenotypes in several cancer types, such as breast cancer [17], melanoma [39], prostate cancer [16] and renal cancer [40].